Anat Ben-Yaacov

Dr. Anat Ben-Yaacov holds a PhD in Biology from the Hebrew University of Jerusalem. Her PhD thesis, under the supervision of Prof. Yael Stern-Bach, focuses on glutamate receptors, the most abundant receptors in the brain, in particular these of the AMPA- type, and their regulation by auxiliary proteins. This was achieved through the identification of the regulatory domains and protein-protein interfaces, employing methods of electrophysiology, biochemistry, and microscopy. Anat has also completed her post-doctoral research in the Cancer Research Center in Sheba Hospital and Tel-Aviv University. Her research topic dealt primarily with RNA modifications and regulation of gene expression. Anat joined IMBM in August 2019. At IMBM she provides biological input to various projects. Currently she is involved in the study of sepsis and its optimal therapy, in collaboration with physicians from the Intensive Care Units (ICU) at Hadassah, Hebrew University medical center.

Publications

  1. Ben-Yaacov A., Gillor M., Haham T., Parsai A., Qneibi M., Stern-Bach Y. (2017) Molecular Mechanism of AMPA Receptor Modulation by TARP/Stargazin. Neuron, 93 (5), 1126-1137.